BioSpace News Archive

FDA

Akorn-Strides, LLC Announces FDA Approval for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials

April 24, 2008
·
4 min read
Drug Development

Valeant Pharmaceuticals International Highlights Taribavirin Phase IIb Data

April 24, 2008
·
1 min read
Drug Development

OctoPlus Presents Positive Locteron Phase IIa Study Results

April 24, 2008
·
5 min read
Drug Development

Gilead Sciences, Inc. Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread(R) for the Treatment of Chronic Hepatitis B

April 24, 2008
·
16 min read
FDA

FDA Approves Biovail Corporation Drug for Depression

April 24, 2008
·
1 min read
Policy

Bristol-Myers Squibb Company Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug

April 24, 2008
·
2 min read
Drug Development

ESBATech’s Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications

April 24, 2008
·
3 min read
Business

Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company

April 24, 2008
·
12 min read
SimBioSys Utilizes Revolutionary Hardware Technology to Open New Frontiers in Molecular Modeling

April 24, 2008
·
2 min read
Business

Derma Sciences, Inc. Announces Agreement With MedAssets, Inc. for MEDIHONEY(TM) Wound & Burn Dressings

April 24, 2008
·
4 min read